Careers  |  Sign In  |  Register

Latest in Neurology & Neurosurgery

Rituximab failed to meet the primary endpoint of stemming the progression of primary-progressive multiple sclerosis (PPMS) in a Phase II/III trial. From Our Partners at VerusMed verusmed.com Sponsored by The Doctor's...
At the American Academy of Neurology meeting, researchers gave final results of the phase III PRECISE trial of glatiramer acetate (Copaxone), which delayed the onset of clinically confirmed multiple sclerosis by more than a year in patients with early signs of the disease. For more information visit: ...

Clinical practice guidelines about pharmacologic treatment of dementia

From VerusMed Neurology

The American College of Physicians and the American Academy of Family Physicians issued clinical practice guidelines about the pharmacologic treatment of dementia. From our partners at VerusMed verusmed.com Sponsored by The Doctor's...